Acquisition

The pipeline giant's record $20B EBITDA is fueled by traditional energy, while it aggressively expands into renewables to power the digital economy.

STADA and Bio-Thera's new golimumab biosimilar wins European approval, promising to slash healthcare costs and expand treatment access for millions.

Japanese giant's all-cash acquisition of Tri Pointe Homes creates a top-5 U.S. builder, raising questions on affordability and market consolidation.

Capgemini's 2025 results show a strong pivot to AI, with bookings soaring and a €700M plan to reshape its workforce for a new era of tech.

As Guardian Pharmacy Services prepares for a key investor conference, it showcases strong growth while its industry faces a looming crisis. Can its model work?

Weatherford deepens its partnership with TotalEnergies, landing a crucial multi-year deal to support Denmark's offshore energy infrastructure.

As Perimeter preps its year-end results, investors are watching if its aggressive diversification can overcome operational hurdles and justify its new shape.

The retail REIT reports record-breaking leasing and strong profits for 2025, while executing a strategic portfolio overhaul and setting a confident tone for 2026.

The industrial giant posted strong 2025 results and a cautious 2026 outlook, banking on its execution strategy and key acquisitions in high-growth markets.

The pet insurance giant swung to a major profit in 2025, but a closer look reveals a complex strategy of focused growth and rising acquisition costs.

Investors eye Globus Medical's upcoming report for a full-year look at its NuVasive integration, market trends, and a pivotal 2025 performance.

The SaaS firm posts strong net income and recurring revenue growth from its B2B platform, offsetting a decline in its transactional business.

Yelp posted record 2025 revenue but forecasts lower 2026 profits as it invests heavily in an AI transformation, including acquiring Hatch and partnering with OpenAI.

Celcuity adds Seagen commercial veteran Charles Romp to its board, a strategic move signaling its pivot from R&D to market readiness for gedatolisib.

DifGen Pharmaceuticals' new FDA-approved generic eye drop is only the second of its kind, promising to increase competition and lower costs for patients.

LA Fitness and Shoot 360 are launching smart basketball courts in their gyms. Can AI and gamification revolutionize how amateurs train and compete?

Telescope giant Celestron's new buy-one, give-one program aims to put a telescope in every school. Can it revolutionize STEM education in America?

France bestows a knighthood on SCAD founder Paula Wallace for her transformative work in arts education and historic preservation in Provence.

Ubisoft reports booming Q3 sales fueled by its top franchises, but a major restructuring, job cuts, and a grim profit forecast paint a complex picture.

A 29-year-old home-selling platform is getting a modern, AI-powered reboot. Can it finally make selling your own home simple, safe, and mainstream?